Kai Yu Li
Papers
1
Total Citations
19
H-Index
1
About
Dr. Kai Yu Li is a pioneering surgical oncologist whose research centers on advancing minimally invasive techniques for pancreatic cancer treatment, with a particular focus on robotic pancreaticoduodenectomy. Dr. Li’s major contribution lies in leveraging large-scale national data to evaluate the safety, efficacy, and outcomes of robotic surgery for pancreatic ductal adenocarcinoma—a malignancy with a notoriously poor 5-year survival rate of just 10.8%. Their landmark study, “New perspectives on robotic pancreaticoduodenectomy: An analysis of the National Cancer Database” (2023, 19 citations), provides critical insights into the real-world application of robotic platforms, demonstrating their potential to improve perioperative outcomes and expand surgical access. This work has helped shape contemporary surgical practice by offering evidence-based perspectives on a rapidly evolving technology. Dr. Li’s research is highly regarded for its methodological rigor and clinical relevance, making significant strides in a field where prognosis remains challenging. With growing citation impact, Dr. Li continues to influence the next generation of surgeons and researchers dedicated to improving survival and quality of life for pancreatic cancer patients.
Research Focus
Key Achievements
Top Papers
- 1